— Know what they know.
Not Investment Advice

Financial News

Sentiment 47.2 5123 articles 2754 bullish 1163 bearish Full Index →
What's Behind The Drop In Reviva Pharmaceuticals Stock?

What's Behind The Drop In Reviva Pharmaceuticals Stock?

Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) are tumbling after the company announced the pricing of its $10 million public offering...
The Great Magnificent 7 Breakup: Nvidia Stands Tall While Te

The Great Magnificent 7 Breakup: Nvidia Stands Tall While Tesla, Microsoft Stumble And Fall

The much-vaunted Magnificent Seven stocks are starting to look a lot less magnificent as a group. In 2026, the market's favorite mega-cap tech...
Gold Tumbles Over 6%; Accenture Earnings Top Views

Gold Tumbles Over 6%; Accenture Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 150 points on Thursday. The Dow traded down 0.81% to...
Gold Tumbles Over 6%; Accenture Earnings Top Views

Gold Tumbles Over 6%; Accenture Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 150 points on Thursday. The Dow traded down 0.81% to...
Sarepta To Request FDA For Traditional Approvals For Duchenn

Sarepta To Request FDA For Traditional Approvals For Duchenne Drugs

Sarepta Therapeutics Inc. (NASDAQ:SRPT) shares are down during Thursday’s session following a regulatory update regarding its treatments for...
The Race to Shield Global Infrastructure from the Coming Qua

The Race to Shield Global Infrastructure from the Coming Quantum Threat

Issued on behalf of Quantum Secure Encryption Corp. VANCOUVER, BC, March 19, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — Think of it as a...
Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss

Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17%

Eli Lilly and Co (NYSE:LLY) shares are down on Thursday. The company released news regarding its investigational drug, retatrutide, which has shown...
📰

Nextech Trims Kymera at a Recent High — think Foolishly before acting.

Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.
📰

Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?

Labcorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?

Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?

Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—TALK, UNF, ACLX, and FONR

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—TALK, UNF, ACLX, and FONR

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
Why Are Semiconductor Chip Stocks Falling On Thursday?

Why Are Semiconductor Chip Stocks Falling On Thursday?

Semiconductor stocks pulled back on Thursday amid geopolitical tensions and supply risks, adding fresh pressure to an already sensitive sector. The...
Dow Falls Over 300 Points; US Initial Jobless Claims Fall

Dow Falls Over 300 Points; US Initial Jobless Claims Fall

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Thursday. Following the market opening Thursday, the...
Dow Falls Over 300 Points; US Initial Jobless Claims Fall

Dow Falls Over 300 Points; US Initial Jobless Claims Fall

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Thursday. Following the market opening Thursday, the...
📰

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of -86.47% and -23.28%, respectively, for the quarter ended December 2025. Do the...
📰

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of -86.47% and -23.28%, respectively, for the quarter ended December 2025. Do the...
📰

PMI DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Picard Medical To Contact Him...
📰

POM DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him...
This Xponential Fitness Analyst Is No Longer Bullish; Here A

This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This Xponential Fitness Analyst Is No Longer Bullish; Here A

This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
📰

RGNX DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In REGENXBIO To Contact Him...
📰

Hyperfine (HYPR) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Wednesday, March 18, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
QURE DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds uniQ

QURE DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UniQure To Contact Him...
What's Going On With bioAffinity Stock Thursday?

What's Going On With bioAffinity Stock Thursday?

bioAffinity Technologies Inc. (NASDAQ:BIAF) shares are down during Thursday’s premarket session. Over the last week, the stock has surged by...
Hologic's Women's Health Index Flags Alarming Gaps in STI Sc

Hologic's Women's Health Index Flags Alarming Gaps in STI Screening

HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
Hologic's Women's Health Index Flags Alarming Gaps in STI Sc

Hologic's Women's Health Index Flags Alarming Gaps in STI Screening

HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
📰

ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses Beta Bionics Stock or...
Pink Slip Pivot: Meta Eyes Massive Layoffs To Feed Its AI Am

Pink Slip Pivot: Meta Eyes Massive Layoffs To Feed Its AI Ambition

Meta Platforms Inc. (NASDAQ:META) is planning significant layoffs to cut costs and fund its growing artificial intelligence investments, underscoring...
📰

Intuitive Surgical and Lennar have been highlighted as Zacks Bull and Bear of the Day

Intuitive Surgical shines on growth and earnings beats, while Lennar faces falling sales, margins, and a prolonged housing market slump.
What's Going On With Aldeyra Therapeutics Stock On Thursday?

What's Going On With Aldeyra Therapeutics Stock On Thursday?

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) shares are down during Thursday’s premarket session following the company’s recent challenges...
📰

Integer Holdings Corporation Investigated by the Portnoy Law Firm

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>LOS...
📰

Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>LOS...
📰

Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>LOS...
📰

SGRY Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates

Surgery Partners (SGRY) Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates Levi & Korsinsky, LLP...
📰

Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW...

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms